Flourtown, PA, United States of America

Yan Shi

USPTO Granted Patents = 40 

 

Average Co-Inventor Count = 5.6

ph-index = 8

Forward Citations = 199(Granted Patents)


Company Filing History:


Years Active: 2001-2025

where 'Filed Patents' based on already Granted Patents

40 patents (USPTO):

Title: Yan Shi: Innovations Paving the Way for Industry Revolution

Introduction:

Throughout her illustrious career, Yan Shi has emerged as an exceptional innovator, consistently pushing the boundaries of what is possible. Her exceptional abilities, commitment to excellence, and groundbreaking inventions have earned her recognition and admiration in the field of patents and innovations. This article highlights Yan Shi's remarkable accomplishments, her latest patents, career highlights, collaborations, and the potential impact of her work.

Latest Patents:

Yan Shi's recent patents include "Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists" and "Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists." These inventions introduce groundbreaking compounds with tremendous potential in the pharmaceutical industry. These compounds, selective LPA receptor inhibitors, demonstrate Yan Shi's aptitude for designing novel molecules that can potentially revolutionize the treatment of various diseases.

Career Highlights:

With an impressive portfolio of 35 patents, Yan Shi has firmly established herself as a trailblazer in the industry. Her inventions have attracted significant attention due to their practicality and potential to transform entire sectors. Yan Shi's dedication to scientific exploration and her ability to think outside the box have been instrumental in her success.

Collaborations:

Yan Shi has collaborated with esteemed companies such as Bristol-Myers Squibb Company (referred to as "BMS" from now on) and Syngene International Limited (referred to as "Syngene"). At BMS, Yan Shi had the opportunity to work alongside industry experts, contributing to the development of innovative solutions in the pharmaceutical domain. Her collaboration with Syngene provided a platform to amplify her inventive capabilities, leveraging their expertise to bring new inventions to life.

Some notable coworkers of Yan Shi include Peter Tai Wah Cheng and Hao Zhang. Together, they have nurtured an environment of creativity and excellence, spurring each other to achieve remarkable milestones.

Conclusion:

Yan Shi's extraordinary journey as an inventor and innovator has culminated in a series of accomplishments that have the potential to revolutionize industries. Her patents demonstrate her ability to think critically and develop novel solutions to address complex challenges. Through collaborations with industry leaders, such as BMS and Syngene, Yan Shi has been able to showcase her capabilities and contribute to pioneering advancements in her field.

As Yan Shi continues to embark on her inventive path, it is safe to say that her future contributions will shape the landscape of innovations and patents. Her commitment to excellence and groundbreaking thinking will continue to have a profound impact on industries and pave the way for a more innovative future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…